Succimer chelation in a patient with mercury-associated parkinsonism
Clin Toxicol (Phila)
.
2024 Jan;62(1):65-66.
doi: 10.1080/15563650.2023.2298883.
Epub 2024 Jan 12.
Authors
Wen-Ching Chen
1
,
Yen-Chen Wu
2
,
Poyin Huang
1
3
4
5
6
7
Affiliations
1
Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
2
School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
3
Department of Neurology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
4
Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
5
Dysphagia Functional Reconstructive Center, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
6
Multidisciplinary Swallowing Center, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
7
Department of Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
PMID:
38214213
DOI:
10.1080/15563650.2023.2298883
No abstract available
MeSH terms
Chelating Agents / therapeutic use
Chelation Therapy
Humans
Mercury Poisoning* / diagnosis
Mercury Poisoning* / drug therapy
Mercury*
Succimer / therapeutic use
Substances
Succimer
Mercury
Chelating Agents